Kerecis

kerecis.com

Kerecis is a biotechnology company that develops, manufactures, and markets regenerative grafts from Omega3-rich fish skin. Their flagship product, Kerecis Omega3 Wound, has received FDA approval and is marketed in the U.S. and internationally. The company has transitioned from research and development to commercialization, experiencing rapid growth and positive patient outcomes. Kerecis utilizes sustainable fish skin sourced from wild Atlantic cod, processed with renewable energy, positioning itself as a pioneer in the cellular therapy market.